Dermatological toxicity of acute lymphoblastic leukemia treatment by protocol ALL IC-BFM 2002
Background. Аcute lymphoblastic leukemia (ALL) in children is not only the most common but also potentially curable disease in 8590% cases. The other side of high effectiveness of modern treatment protocols their toxicity. Inspite of skin and mucosal toxicity is not a life threatening condition, it...
Saved in:
Main Authors: | Timur T. Valiev (Author), Tatiana S. Belysheva (Author) |
---|---|
Format: | Book |
Published: |
ZAO "Consilium Medicum",
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-utility of Protocols of BFM-ALL and UK-ALL for Treatment of Children with Acute Lymphoblastic Leukemia in Iran
by: Hadi HAYATI, et al.
Published: (2018) -
Success of induction therapy in acute lymphoblastic leukemia (ALL) in children as per modified BFM-2002 in a tertiary care government hospital
by: Kaushambi Basu, et al.
Published: (2017) -
ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol
by: Yu Wang, et al.
Published: (2018) -
Treatment of pediatric acute lymphoblastic leukemia in India on BFM 95 protocol backbone with relevant modifications and minimal residual disease application - Doable and effective
by: Dhwanee Thakkar, et al.
Published: (2022) -
Prevalence of osteonecrosis in survivors of childhood acute lymphoblastic leukaemia of Indian ethnicity treated with BFM protocol
by: Sanjeev Khera, et al.
Published: (2024)